Please login to the form below

Not currently logged in
Email:
Password:

Chlamydia test approved for use in EU

A new test for chlamydia, produced by pharmaceutical company Roche, has received CE Mark certification, allowing it to be sold in the EU for clinical use
A new test for chlamydia, produced by pharmaceutical company Roche, has received CE Mark certification, allowing it to be sold in the EU for clinical use.

Chlamydia trachomatis is the most commonly diagnosed STI in England, with approximately two-thirds of cases affecting younger age groups. The infection often has no obvious symptoms and left undetected it will not only continue to be spread through the community, but can also lead to complications such as pelvic inflammatory disease or infertility in women.

"Unexpected mutations in the DNA of an infectious agent such as chlamydia can disrupt laboratory testing and, by extension, proper treatment of patients," said Dr Teresa L. Wright, OBE, chief medical officer at Roche Molecular Diagnostics.

This test, known as COBAS TaqMan CT Test v2.0, differs from other tests as it uses a dual target approach helping to ensure reliability even when mutations occur within the bacteria's DNA.

Using specifically designed analysis equipment, results can be obtained just two and a half hours after a sample is prepared.

13th June 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics